Answers are grounded in this paper and cite their sources.
The baseline characteristics of antiretroviral-naive patients were compared by ethnic/racial groups. First CD4 T cell counts were lower for Latino (P= 0.0004) and black patients (P= 0.10) when compared with white patients. First HIV-1-RNA levels were higher in Latino patients (P= 0.08), who were also more likely to present with major opportunistic infections (P< 0.004). Once in care, changes in CD4 T cell counts and viral loads over time did not differ significantly between groups. Two-thirds of the individuals reported with AIDS in the United States in 2000 were from minority populations [1]. Previous analyses have also shown racial differences in survival with AIDS; compared with white patients, black and Hispanic patients have significantly shorter survival times [2,3]. More recent improvements in antiretroviral therapy have produced decreases in mortality rates in the USA, but these are less pronounced for minority groups. Between 1998 and 1999, mortality rates for HIV-1-infected white adults fell by 15%, but only by 3% for black individuals [1]. Access to quality care plays an important role in outcome, and has been shown to be inferior for black and Latino patients with HIV-1 infection [4], with delayed medical care after HIV diagnosis being greater for Latino patients and, to a lesser extent, black compared with white patients [5]. Observations from our HIV clinic were of an increasingly large Latino population typically presenting late in the course of HIV disease. Once in care, however, Latino patients appeared to respond as well as other racial/ethnic groups. We examined these hypotheses by means of a retrospective analysis. All antiretroviral-naive HIV-1-infected patients presenting to the University of Nebraska Medical Center HIV Clinic between January 1996 and July 2001 were included in the analysis. The clinic database was queried for the following: patient demographics, probable HIV transmission route, CD4 T cell counts, HIV-1-RNA measurement (Roche Amplicor HIV-1 Monitor test; Roche, Indianapolis, IN, USA) and the presence or absence of AIDS-defining opportunistic disease [6]. The square root of the baseline CD4 T cell count and the log (HIV-1-RNA level) and changes over time were modelled as a function of various predictors, including age, sex and race/ethnicity, using generalized estimating equation methodology [7]. The square root of the baseline CD4 cell count and the log (HIV-RNA level) were used because the transformed data were more nearly normally distributed. Of the 372 individuals included, 26% were female, 56% were white, 25% were black and 16% were Hispanic. A total of 48% had been infected by homosexual exposure, 40% by heterosexual exposure, and 9% by intravenous drug use. The mean CD4 T cell count at the first visit was 356 cells/mm3 (median 320, range 2–1428) and the mean HIV-1-RNA level was 101 140 copies/ml (median 27 207, range 25–943 573). Significant differences were found in the distribution of ‘first visit’ CD4 T cell counts. Hispanic patients had lower median counts (median 220 cells/mm3, n = 50) when compared with black (median 318 cells/mm3, n = 76) or white patients (median 372 cells/mm3, n = 178;P = 0.01, Wilcoxon test) (Table 1). The distribution of HIV-1-RNA levels also differed significantly. The initial median viral load for white patients was 25 026 copies/ml and for black patients it was 21 439 copies/ml, whereas the median value for Hispanic patients was 64 121 copies/ml (P = 0.08). Linear regression modelling showed that compared with white patients, the ‘first visit’ CD4 T cell counts for Hispanic patients were much lower (P = 0.0004); but for black patients only somewhat lower (P = 0.10) (Table 1). Presenting HIV-1-RNA levels for Hispanic patients were significantly higher when compared with those for white patients (P = 0.0008), but no statistical difference was seen between white and black patients (P = 0.21). The ‘first visit’ CD4 T cell counts appeared to be higher (P = 0.008) and the initial RNA levels lower (P = 0.004) for women compared with men, as previously described [8,9]. The age group (age < 35 versus > 35 years) was not predictive of the ‘first visit’ CD4 T cell count or viral load, after adjusting for sex and race/ethnicity (P = 0.17 and P = 0.256, respectively). At presentation, 11% (n = 23) of white participants and 13% (n = 12) of black participants had a major opportunistic infection. In contrast, 29% (n = 17) of Hispanic participants presented with a major opportunistic infection (P < 0.004).Table 1: Observed median CD4 T cell count and HIV-1-RNA level at presentation by sex and race/ethnicity. Over time, the predicted mean change in the CD4 T cell count from baseline increased significantly in increments of approximately 50 cells/mm3 for each 6-month period in all groups. None of the participant characteristic variables assessed (age, sex, race/ethnicity) was predictive of changes in the CD4 T cell count from baseline over time. A model was fitted to estimate the expected proportion of participants with HIV-RNA levels of less than 400 copies/ml as a function of follow-up time and participant characteristics. The estimated proportion of subjects with levels of less than 400 copies/ml increased over time. Compared with white patients, black (P = 0.03) but not Hispanic patients (P = 0.32) had statistically significantly lower proportions of HIV-RNA levels of less than 400 copies/ml. This study indicates that patients from minority populations, especially Latino individuals, present with more advanced HIV disease when compared with white individuals, and that Latino individuals are significantly more likely to have a major opportunistic infection at presentation. However, once in care, increases in CD4 T cell counts and deceases in viral loads were no different for Latino than for white participants. Viral loads in follow-up appeared to be higher in black compared with white patients. Disparities in access to medical care are influenced by geography, socioeconomic status and insurance status [4]. Barriers to care for Latino individuals include language, immigration status, and concern about stigma and discrimination [10]. Latino individuals are also more likely to lack adequate transportation, and have other competing subsistence needs, further complicating access to care [11]. However, previous studies in military personnel have shown no association between viral load and race or ethnicity among adults for whom access to care and socioeconomic status were not confounding factors [12]. These data suggest that given a ‘level playing field', outcomes may not vary by race/ethnicity. Our clinic services are supported by the Ryan White CARE Act Title III program, which funds comprehensive outpatient services to low- income, uninsured and underinsured individuals, and provides access to care regardless of ability to pay. The Centers for Disease Control and Prevention has also recently launched a major initiative expanding HIV prevention programs based on serostatus [13]. An important goal of the program is to increase the numbers of HIV-positive individuals who know their serostatus and are linked to healthcare services. Efforts should continue to be made to provide access to culturally appropriate care for minority populations with HIV disease, and to encourage earlier diagnosis and treatment. Susan Swindellsa Daniel G. Cobosa Nancy Leeb Elizabeth A. Liena Ann P. Fitzgeralda Jennifer S. Paulsc James R. Andersonc Acknowledgements The authors would like to thank the University of Nebraska Title III Program staff for their hard work and dedication, and in particular Deanna Hansen for outstanding administrative support.
No takes yet. Share an insight, caveat, or question.
Swindells et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: